Amlodipine Besylate
NDC Package 16590-295-30

11-digit billing NDC: 16590029530

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Amlodipine Besylate is hypertension                                                                                                                                                                               Amlodipine is indicated for the treatment of hypertension. Marketed by Stat Rx Usa Llc, this product is identified by NDC 16590-295 and is authorized under FDA application ANDA078500.

Identification & Billing

NDC Package Code
16590-295-30
Package Description
30 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
16590029530
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Amlodipine Besylate
Dosage Form
-
Usage Information
Hypertension                                                                                                                                                                               Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.Coronary Artery Disease (CAD)Chronic Stable AnginaAmlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal agents.Vasospastic Angina (Prinzmetal's or Variant Angina)Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal drugs.Angiographically Documented CAD In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, amlodipine besylate tablets are indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.

Regulatory & Marketing

Labeler Name
Stat Rx Usa Llc
FDA Application #
ANDA078500
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-06-2007
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16590-295-30 identifies a specific commercial package of 30 tablet in 1 bottle of Amlodipine Besylate, labeled by Stat Rx Usa Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa Llc on September 06, 2007. The current certification is valid through December 31, 2017.

How is this Stat Rx Usa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590029530. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16590-295-30
11-Digit CMS (5-4-2)
16590-0295-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.